Zoledronic acid Stada
Recall
|
Medicines
|
14/02/2018
The marketing authorization holder has informed its supplied customers in a letter dated February 13, 2018, that a minor contamination with Iopamidol has been detected in batch PQ0968 of the medicinal product "Zoledronic Acid STADA 4 mg/100 ml Infusion Solution". This can lead to adverse effects in correspondingly sensitized persons. Therefore, the batch is recalled as a precautionary measure.
Name of the medicinal product | Zoledronsäure STADA 4mg/100ml Infusionslösung |
---|---|
Marketing authorisation number(s) | 1-35317 |
Marketing authorisation holder | STADA Arzneimittel GmbH |
Batch number(s) | PQ0968 |
Classification of the recall | 2 |
BASG reference number | INS-640.001-2451 |
Further inquiry note
Page last modified:
12/07/2022